Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Foghorn Therapeutics Inc
(NQ:
FHTX
)
5.900
-0.140 (-2.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Foghorn Therapeutics Inc
< Previous
1
2
3
4
Next >
Foghorn Therapeutics to Present New Preclinical Data for BRG1/BRM Inhibitor FHD-286 in Combination with Anti-PD-1 Antibody at Society for Immunotherapy of Cancer 37th Annual Meeting
November 09, 2022
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update
November 08, 2022
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Foghorn Therapeutics Appoints Dr. Thomas J. Lynch, Jr. to Its Board of Directors
October 27, 2022
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
4 Analysts Have This to Say About Foghorn Therapeutics
August 10, 2022
Analysts have provided the following ratings for Foghorn Therapeutics (NASDAQ:FHTX) within the last quarter:
Via
Benzinga
FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial
May 20, 2022
Via
Benzinga
Foghorn Therapeutics Announces New Data Demonstrating BRD9 Degradation in Patient Tumor Biopsies and Discloses New Selective CBP Program
October 26, 2022
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Foghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation Summit
October 20, 2022
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
September 30, 2022
Gainers
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Gainers
Via
Benzinga
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
September 19, 2022
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
August 24, 2022
Via
Benzinga
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
August 24, 2022
Gainers
Via
Benzinga
Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher
August 23, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday.
Via
Benzinga
Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday
August 23, 2022
GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.
Via
Benzinga
Nasdaq Turns Lower; Crude Oil Rises Sharply
August 23, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday.
Via
Benzinga
US Stocks Mixed; Dow Falls 50 Points
August 23, 2022
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday.
Via
Benzinga
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
August 23, 2022
Gainers
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5%
May 23, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday.
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge
May 23, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday.
Via
Benzinga
30 Stocks Moving In Monday's Mid-Day Session
May 23, 2022
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.
Via
Benzinga
66 Biggest Movers From Friday
May 23, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
Via
Benzinga
Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump
May 20, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday.
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
May 20, 2022
Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Deere Tops Q2 Views
May 20, 2022
U.S. stocks traded higher this morning, with the Dow Jones dropping around 150 points on Friday.
Via
Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
10 Biggest Price Target Changes For Friday
May 20, 2022
Telsey Advisory Group lowered the price target for Best Buy Co., Inc. (NYSE: BBY) from $130 to $90. Best Buy shares rose 0.4% to $73.58 in pre-market trading.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 20, 2022
Good morning! We're closing in on the end of the week for trading as we go over the biggest pre-market stock movers for Friday!
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.